QPOLE : A Quick, Simple, and Cheap Alternative for POLE Sequencing in Endometrial Cancer by Multiplex Genotyping Quantitative Polymerase Chain Reaction
JCO Global Oncology · 2023-05 · (9)
DOI: 10.1200/go.22.00384 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Global Oncology, 2023-05. Verfasst von Anne Sophie V M Van den Heerik und 19 weiteren Autor:innen. Beteiligte Einrichtung: Radiation Oncology, Leiden University Medical Center (LUMC), Leiden, the Netherlands. Hauptthemen laut MEDLINE: Endometrial Neoplasms. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
PURPOSE Detection of 11 pathogenic variants in the POLE gene in endometrial cancer (EC) is critically important to identify women with a good prognosis and reduce overtreatment. Currently, POLE status is determined by DNA sequencing, which can be expensive, relatively time-consuming, and unavailable in hospitals without specialized equipment and personnel. This may hamper the implementation of POLE-testing in clinical practice. To overcome this, we developed and validated a rapid, low-cost POLE hotspot test by a quantitative polymerase chain reaction (qPCR) assay, QPOLE. MATERIALS AND METHODS Primer and fluorescence-labeled 5′-nuclease probe sequences of the 11 established pathogenic POLE mutations were designed. Three assays, QPOLE-frequent for the most common mutations and QPOLE-rare-1 and QPOLE-rare-2 for the rare variants, were developed and optimized using DNA extracted from formalin-fixed paraffin-embedded tumor tissues. The simplicity of the design enables POLE status assessment within 4-6 hours after DNA isolation. An interlaboratory external validation study was performed to determine the practical feasibility of this assay. RESULTS Cutoffs for POLE wild-type, POLE-mutant, equivocal, and failed results were predefined on the basis of a subset of POLE mutants and POLE wild-types for the internal and external validation. For equivocal cases, additional DNA sequencing is recommended. Performance in 282 EC cases, of which 99 were POLE-mutated, demonstrated an overall accuracy of 98.6% (95% CI, 97.2 to 99.9), a sensitivity of 95.2% (95% CI, 90.7 to 99.8), and a specificity of 100%. After DNA sequencing of 8.8% equivocal cases, the final sensitivity and specificity were 96.0% (95% CI, 92.1 to 99.8) and 100%. External validation confirmed feasibility and accuracy. CONCLUSION QPOLE is a qPCR assay that is a quick, simple, and reliable alternative for DNA sequencing. QPOLE detects all pathogenic variants in the exonuclease domain of the POLE gene. QPOLE will make low-cost POLE-testing available for all women with EC around the globe.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Radiation Oncology, Leiden University Medical Center (LUMC), Leiden, the Netherlands.
- Pathology, Leiden University Medical Center (LUMC), Leiden, the Netherlands.
- Radiation Oncology, Medisch Spectrum Twente, Enschede, the Netherlands.
- Pathology, Laboratorium Pathologie Oost-Nederland, Hengelo, the Netherlands.
- Department of Gynaecology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
- Department of Pathology, Copenhagen University Hospital, Herlev and Gentofte Hospital, Copenhagen, Denmark.
ORCID-Profile: Anne Sophie V M Van den Heerik, Lisa Vermij, Jan J Jobsen, Mariel Brinkhuis, Gitte Ortoft, Estrid Hogdall, Tom Van Wezel, Ludy C H W Lutgens, Marie A D Haverkort, Carien L Creutzberg, Vincent T H B M Smit, C Blake Gilks, Nanda Horeweg, Tjalling Bosse
Zitieren
APA
Van den Heerik, A. S. V. M., Ter Haar, N. T., Vermij, L., Jobsen, J. J., Brinkhuis, M., Roothaan, S. M., Leon-Castillo, A., Ortoft, G., Hogdall, E., Hogdall, C., Van Wezel, T., Lutgens, L. C. H. W., Haverkort, M. A. D., Khattra, J., McAlpine, J. N., Creutzberg, C. L., Smit, V. T. H. B. M., Gilks, C. B., Horeweg, N., & Bosse, T. (2023). QPOLE : A Quick, Simple, and Cheap Alternative for POLE Sequencing in Endometrial Cancer by Multiplex Genotyping Quantitative Polymerase Chain Reaction. JCO Global Oncology. https://doi.org/10.1200/go.22.00384
Vancouver
Van den Heerik ASVM, Ter Haar NT, Vermij L, Jobsen JJ, Brinkhuis M, Roothaan SM, et al. QPOLE : A Quick, Simple, and Cheap Alternative for POLE Sequencing in Endometrial Cancer by Multiplex Genotyping Quantitative Polymerase Chain Reaction. JCO Global Oncology. 2023. doi:10.1200/go.22.00384
BibTeX
@article{VandenHeerik2023,
author = {Van den Heerik, Anne Sophie V M and Ter Haar, Natalja T and Vermij, Lisa and Jobsen, Jan J and Brinkhuis, Mariel and Roothaan, Suzan M and Leon-Castillo, Alicia and Ortoft, Gitte and Hogdall, Estrid and Hogdall, Claus and Van Wezel, Tom and Lutgens, Ludy C H W and Haverkort, Marie A D and Khattra, Jas and McAlpine, Jessica N and Creutzberg, Carien L and Smit, Vincent T H B M and Gilks, C Blake and Horeweg, Nanda and Bosse, Tjalling},
title = {QPOLE : A Quick, Simple, and Cheap Alternative for POLE Sequencing in Endometrial Cancer by Multiplex Genotyping Quantitative Polymerase Chain Reaction},
journal = {JCO Global Oncology},
year = {2023},
number = {9},
doi = {10.1200/go.22.00384}
}
EUVIMED